Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Chinese Medical Journal ; (24): 1014-1020, 2015.
Article in English | WPRIM (Western Pacific) | ID: wpr-350359

ABSTRACT

<p><b>BACKGROUND</b>Inconsistencies in the use of the vasoactive agent therapy to treat shock are found in previous studies. A descriptive study was proposed to investigate current use of vasoactive agents for patients with shock in Chinese intensive care settings.</p><p><b>METHODS</b>A nationwide survey of physicians was conducted from August 17 to December 30, 2012. Physicians were asked to complete a questionnaire which focused on the selection of vasoactive agents, management in the use of vasopressor/inotropic therapy, monitoring protocols when using these agents, and demographic characteristics.</p><p><b>RESULTS</b>The response rate was 65.1% with physicians returning 586 valid questionnaires. Norepinephrine was the first choice of a vasopressor used to treat septic shock by 70.8% of respondents; 73.4% of respondents favored dopamine for hypovolemic shock; and 68.3% of respondents preferred dopamine for cardiogenic shock. Dobutamine was selected by 84.1%, 64.5%, and 60.6% of respondents for septic, hypovolemic, and cardiogenic shock, respectively. Vasodilator agents were prescribed by physicians in the management of cardiogenic shock (67.1%) rather than for septic (32.3%) and hypovolemic shock (6.5%). A significant number of physicians working in teaching hospitals were using vasoactive agents in an appropriate manner when compared to physicians in nonteaching hospitals.</p><p><b>CONCLUSIONS</b>Vasoactive agent use for treatment of shock is inconsistent according to self-report by Chinese intensive care physicians; however, the variation in use depends upon the form of shock being treated and the type of hospital; thus, corresponding educational programs about vasoactive agent use for shock management should be considered.</p>


Subject(s)
Humans , Data Collection , Dobutamine , Therapeutic Uses , Dopamine , Therapeutic Uses , Intensive Care Units , Norepinephrine , Therapeutic Uses , Shock , Drug Therapy , Shock, Cardiogenic , Drug Therapy , Shock, Septic , Drug Therapy , Surveys and Questionnaires , Vasoconstrictor Agents , Therapeutic Uses , Vasodilator Agents , Therapeutic Uses
2.
J Org Chem ; 70(13): 4954-61, 2005 Jun 24.
Article in English | MEDLINE | ID: mdl-15960492

ABSTRACT

A novel, highly stereoselective synthesis of an azaspirocyclic core, which contains four stereogenic carbons consistent with structures of natural halichlorine and pinnaic acid, is presented. Lipase PS-catalyzed selective acylation, asymmetric methylation on the alpha-methylene of the bicyclic lactone, and an asymmetric Michael addition of the tertiary nitro cyclopentane were concisely used to conquer the challenging problem of successfully constructing the C9 quarternary carbon center with complete stereocontrol. The spiropiperidine ring was formed by reduction of the delta-nitroketone, intramolecular condensation, and then highly stereoselective reduction of the cyclic nitrone with NaBH(4). This spirocyclic core is a key intermediate in Danishefsky's synthesis of pinnaic acid and halichlorine.


Subject(s)
Alkaloids/chemical synthesis , Aza Compounds/chemical synthesis , Combinatorial Chemistry Techniques , Spiro Compounds/chemical synthesis , Alkaloids/chemistry , Aza Compounds/chemistry , Catalysis , Indicators and Reagents , Molecular Structure , Spiro Compounds/chemistry , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL